| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/13/1994 | CA2159916A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 10/13/1994 | CA2159639A1 Method for selective inactivation of viral replication |
| 10/13/1994 | CA2159630A1 7-deazapurine modified oligonucleotides |
| 10/13/1994 | CA2159629A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
| 10/13/1994 | CA2159628A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 10/13/1994 | CA2159359A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic |
| 10/13/1994 | CA2159350A1 Modified oligonucleotides having improved anti-influenza activity |
| 10/13/1994 | CA2158554A1 Pharmaceuticals based on papillomaviruses |
| 10/13/1994 | CA2158171A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 10/13/1994 | CA2135671A1 Diamine salts of clavulanic acid |
| 10/12/1994 | EP0619311A1 Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof |
| 10/12/1994 | EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 10/12/1994 | EP0618925A1 Gapped 2' modified oligonucleotides |
| 10/12/1994 | EP0618804A1 Peptides corresponding to antigenic determinants of htlv |
| 10/12/1994 | EP0618800A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 10/12/1994 | EP0494294B1 Bacterial stress proteins |
| 10/12/1994 | EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 10/12/1994 | EP0433428B1 A stable form of cephradine, process for its production and intermediates used therein |
| 10/12/1994 | EP0425566B1 New photosensitizing agents |
| 10/12/1994 | EP0407478B1 Crystalline (5r,6s)-2-carbamoyloxymethyl-6- (1r)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation |
| 10/12/1994 | CN1093366A Crystalline carbapenem derivative |
| 10/11/1994 | US5354902 Stabilized sorbic acid or salt thereof |
| 10/11/1994 | US5354844 Protein-polycation conjugates |
| 10/11/1994 | US5354748 Cilastin as an inhibitor of the dipeptidase-like enzyme localized on/in epithelial cells of the small intestine |
| 10/11/1994 | CA1332353C Pharmaceutical composition for the treatment of skin wounds |
| 10/05/1994 | EP0618226A1 Inhibitors of herpes viral ribonculeotide reductase |
| 10/05/1994 | EP0618222A2 Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid |
| 10/05/1994 | EP0618214A1 Unsaturated phosphonate derivatives of purines and pyrimidines |
| 10/05/1994 | EP0618198A1 Process for the preparation of 1,3-bis (1,2,4-triazol-1-yl)-propan-2-ol derivatives |
| 10/05/1994 | EP0618190A1 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 10/05/1994 | EP0617968A1 HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS |
| 10/05/1994 | EP0617958A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 10/05/1994 | EP0539460B1 Salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii b |
| 10/05/1994 | EP0436690B1 Extracts of the acanthospermum hispidum plant |
| 10/05/1994 | CN1093089A Cephalosporin salts and process for the preparation thereof |
| 10/05/1994 | CN1026115C Novel S-adenosyl methionine inhibitors |
| 10/04/1994 | US5352792 Thioalkylthio cephalosporin derivatives |
| 10/04/1994 | CA1332234C Synthetic receptor analogues |
| 10/01/1994 | CA2120192A1 Hiv protease inhibitors useful for the treatment of aids |
| 09/30/1994 | CA2119995A1 Processes for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021812A2 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | WO1994021807A2 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021685A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | WO1994021684A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994021677A1 Aza cyclohexapeptide compounds |
| 09/29/1994 | WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/29/1994 | WO1994021649A1 Crystalline benzathine salt of cefonicid and its preparation |
| 09/29/1994 | WO1994021642A1 Macrocyclic amide and urea immunomodulators |
| 09/29/1994 | WO1994021633A1 Carbacephalosporin compound, their preparation and use |
| 09/29/1994 | WO1994021604A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 09/29/1994 | WO1994021295A1 Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 09/29/1994 | WO1994021292A1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
| 09/29/1994 | WO1994021284A1 Therapeutic formulation and method |
| 09/29/1994 | WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 09/29/1994 | WO1994021269A1 Drugs for the treatment of retrovirus infections |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994021127A1 Mucosal competitive exclusion flora |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | CA2158866A1 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | CA2158748A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | CA2158658A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | CA2158564A1 Parvovirus receptors and methods of use |
| 09/29/1994 | CA2158551A1 Drugs for the treatment of retrovirus infections |
| 09/29/1994 | CA2158252A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | CA2158148A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
| 09/29/1994 | CA2156065A1 Macrocyclic amide and urea immunomodulators |
| 09/29/1994 | CA2155739A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/28/1994 | EP0617128A1 Recombinant vaccine for porcine pleuropneumonia |
| 09/28/1994 | EP0617124A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 09/28/1994 | EP0617036A2 Novel 2-thiosubstituted carbapenems |
| 09/28/1994 | EP0617031A1 Orally active azole derivates |
| 09/28/1994 | EP0617024A1 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 09/28/1994 | EP0616535A1 Method of treating viral infections |
| 09/28/1994 | EP0539451B1 Vinylsulphonyl pristinamycin and preparation thereof |
| 09/28/1994 | EP0408742B1 Method for production and purification of hepatitis b vaccine |
| 09/28/1994 | CN1092812A Vaccines |
| 09/28/1994 | CN1092773A Novel antimicrobial 5-(N-heterosubstituted amino) quinolones |
| 09/27/1994 | US5350861 Substituted 3-aryl-pyrrolidine-2,4-diones |
| 09/27/1994 | US5350854 2-substituted tertiary carbinol derivative of 1,5-iminosugars |
| 09/27/1994 | US5350772 Certain substituted phenoxy-methyl phenyl-methoxy benzenes having antiviral activity |
| 09/27/1994 | US5350764 Anticoccidial and growth promoting polycyclic ether antibiotic |
| 09/27/1994 | US5350758 Anticholesterol agents |
| 09/27/1994 | US5350753 Treatment of bacterial infectious diseases and septic shock |
| 09/27/1994 | CA1332171C Quinolinecarboxylic acid derivatives and antibacterial agent containing the same |
| 09/21/1994 | EP0615969A1 2,4-Diamino-3-hydroxycarboxylic acid derivatives |
| 09/21/1994 | EP0615752A1 Treatment of viral infections |
| 09/21/1994 | EP0557389B1 Direct compression method for preparing pills having cephalosporanic acid derivatives |
| 09/21/1994 | EP0481013B1 A composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 09/21/1994 | EP0440688B1 Cpf peptide compositions and uses |
| 09/21/1994 | EP0371017B1 Antibodies against streptococcus |
| 09/21/1994 | CN1092427A Enantiomerically pure SS-D-dioxolane nucleosides with selective anti-hepatitis B virus activity |
| 09/21/1994 | CN1092410A Inhibitors of HIV protease useful for the treatment of aids |
| 09/21/1994 | CN1092322A Method of treating hepatitis C in non-responders to interferon treatment |